ACADIA Pharmaceuticals Inc. ACAD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.43% | 18.13% | -80.84% | 90.32% | 119.07% |
| Total Depreciation and Amortization | 23.83% | 7.56% | 1.42% | -43.92% | 14.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 163.92% | 108.24% | 52.75% | -70.87% | -48.42% |
| Change in Net Operating Assets | -519.46% | 83.11% | 221.33% | -390.06% | -378.57% |
| Cash from Operations | -84.52% | 57.58% | 67.20% | -220.68% | 17.46% |
| Capital Expenditure | -219.59% | -1,613.47% | -- | -784.11% | -454.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.53% | 92.00% | 157.63% | -116.90% | 4.15% |
| Cash from Investing | -8.57% | 80.30% | 153.43% | -145.74% | 3.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.98% | -34.23% | 130.20% | 1,051.14% | 3,416.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.98% | -34.23% | 130.20% | 1,051.14% | 3,416.04% |
| Foreign Exchange rate Adjustments | -- | 12.50% | 600.00% | 111.67% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,536.57% | 180.48% | 202.58% | -149.82% | 122.96% |